文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

全球伤寒沙门菌耐药性更新系统综述

An updated systematic review on antimicrobial resistance among Salmonella Typhi worldwide.
PubMed 文献 · Clin Microbiol Infect · 2026-08-14

结果显示30.7%为多重耐药,42.4%对环丙沙星耐药,3.4%对阿奇霉素耐药;非洲多重耐药比例逐十年上升,亚洲下降,亚洲出现广泛耐药株。

要点

  • 全球伤寒沙门菌多重耐药占比30.7%,环丙沙星耐药42.4%,阿奇霉素耐药3.4%。
  • 非洲多重耐药比例自1990年起逐十年上升,亚洲则下降。
  • 广泛耐药伤寒沙门菌在巴基斯坦占58.0%,提示亚洲区域出现。

核心结论

  • 非洲多重耐药伤寒沙门菌扩展及亚洲广泛耐药株出现,危及伤寒治疗,支持包括疫苗接种在内的预防措施。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Web of Science和预印本库至2025年11月30日,纳入报告无菌部位伤寒沙门菌药敏结果的研究。

主要发现

  • 自1990年起按十年计算,非洲多重耐药沙门菌中位比例逐十年上升,亚洲下降。

临床怎么用

  • 经验性治疗伤寒时应考虑当地多重耐药和环丙沙星耐药高发,非洲多重耐药上升趋势支持疫苗接种等预防措施。

局限性

  • 1289个估计中1172个(90.9%)基于医疗机构,可能影响代表性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Updated evidence on antimicrobial resistance (AMR) among Salmonella Typhi is needed to inform empiric treatment and typhoid prevention, including vaccine introduction. OBJECTIVES: To update our 2020 systematic review on prevalence and trends of AMR among Salmonella Typhi. METHODS: Data sources: PubMed, Web of Science, and preprint repositories from database inception through 30 November 2025, citation searching, and contacting authors of new reports. STUDY ELIGIBILITY CRITERIA: We included studies reporting antimicrobial susceptibility testing results of Salmonella Typhi isolated from a normally sterile site in a person. RISK OF BIAS ASSESSMENT: We adapted the Joanna Briggs Institute guidance for critical appraisal on prevalence studies. DATA SYNTHESIS METHODS: We calculated the proportion of resistant isolates for each antimicrobial tested by dividing the number of resistant isolates by the total number of isolates tested. We computed by decade the median proportions of isolates resistant by United Nations region and performed chi-squared test for trend in proportions. RESULTS: Of 411 included reports tested, 132 174 Salmonella Typhi were isolated from 1972 through 2024 across 54 countries, of which 114 907 (86.9%) were from Southern Asia. Of 1289 estimates, 1172 (90.9%) were facility based. Of Salmonella Typhi isolates assessed, 22 320 (30.7%) of 72 731 were multidrug-resistant (MDR), 41 225 (42.4%) of 97 269 resistant to ciprofloxacin, and 2086 (3.4%) of 62 186 resistant to azithromycin. From 1990, by decade, the median proportion of MDR Salmonella Typhi increased by consecutive decade for Africa and decreased for Asia. Of isolates in countries reporting extensively drug-resistant (XDR) Salmonella Typhi, 20 954 (58.0%) of 36 153 were from Pakistan, 1 (16.7%) of 6 from China Hong Kong Special Administrative Region, 10 (0.5%) of 1880 from India, and 3 (0.4%) of 736 from Laos. CONCLUSION: The expansion of MDR Salmonella Typhi in Africa and regional emergence of XDR Salmonella Typhi in Asia compromise typhoid treatment and support typhoid prevention, including by vaccination.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Murthy S, Hagedoorn NN, Adhy WP, et al. An updated systematic review on antimicrobial resistance among Salmonella Typhi worldwide. Clin Microbiol Infect. 2026. PMID: 42601018. doi:10.1016/j.cmi.2026.08.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。